Teva Pharmaceuticals USA, Inc. portfolio
United States
Every trademark Teva Pharmaceuticals USA, Inc. holds, newest filings first. The portfolio has 648 marks filed under 4 owner names.
Search this portfolio
- Trademarks on file
- 648
- Active
- 132
- Owner names grouped
- 4
Portfolio
All trademarks
50 marks per page, newest filing date first. Pick an office to narrow the list.
| Mark | Status | Office | Classes | Filed |
|---|---|---|---|---|
| GOMOSDI | examining | USPTO | 5 | 2026-09-15 |
| DEJEVMA | pending publication | USPTO | 5 | 2026-08-04 |
| WILPAXA | pending publication | USPTO | 5 | 2026-06-11 |
| OLZENDY | pending publication | USPTO | 5 | 2026-06-10 |
| WELTRUZA | allowed | USPTO | 5 | 2026-01-15 |
| TOTAL SUPPORT | pending opposition | USPTO | 35, 36, 38, 41, 42, 44 | 2025-10-20 |
| TEVA TOTAL SUPPORT | examining | USPTO | 35, 36, 38, 41, 42, 44 | 2025-10-20 |
| TEVA TOTAL SUPPORT | examining | USPTO | 35, 36, 38, 41, 42, 44 | 2025-10-14 |
| SIMLANDI | registered | USPTO | 5 | 2025-10-02 |
| TRUOZA | allowed | USPTO | 5 | 2025-03-26 |
| MIZKO | allowed | USPTO | 5 | 2025-03-12 |
| HYBISCA | abandoned | USPTO | 5 | 2025-01-15 |
| ONHIRA | abandoned | USPTO | 5 | 2025-01-15 |
| AVRILLA | abandoned | USPTO | 5 | 2025-01-09 |
| LIMHU | abandoned | USPTO | 5 | 2025-01-09 |
| HUZALDA | abandoned | USPTO | 5 | 2025-01-09 |
| DALHIRA | abandoned | USPTO | 5 | 2025-01-09 |
| DALHU | abandoned | USPTO | 5 | 2025-01-09 |
| SIMLANDI (ADALIMUMAB-RYVK) INJECTION 40MG/0.4ML | abandoned | USPTO | 5, 10 | 2024-11-13 |
| GOMOSDI | registered | EUIPO | 5 | 2024-10-30 |
| IMOSIPA | registered | EUIPO | 5 | 2024-10-30 |
| GOSEMDO | registered | EUIPO | 5 | 2024-10-30 |
| GOMOSDI | registered | UKIPO | 5 | 2024-10-30 |
| GOSEMDO | registered | UKIPO | 5 | 2024-10-30 |
| DRALYEE | registered | UKIPO | 5 | 2024-10-30 |
| IMOSIPA | registered | UKIPO | 5 | 2024-10-30 |
| GOSEMDO FUSA | abandoned | USPTO | 5 | 2024-10-24 |
| IMOSIPA FUSA | allowed | USPTO | 5 | 2024-10-24 |
| GOMOSDI FUSA | allowed | USPTO | 5 | 2024-10-24 |
| GOSEMDO VICI | abandoned | USPTO | 5 | 2024-10-24 |
| IMOSIPA VICI | abandoned | USPTO | 5 | 2024-10-24 |
| GOMOSDI VICI | allowed | USPTO | 5 | 2024-10-24 |
| ZINFAMEL | abandoned | USPTO | 5 | 2024-10-15 |
| GOSEMDI | registered | EUIPO | 5 | 2024-04-10 |
| RIVELSA | registered | USPTO | 5 | 2024-03-12 |
| CONNECTD | registered | USPTO | 44 | 2023-08-16 |
| COVLA | abandoned | USPTO | 5 | 2023-08-14 |
| SHARED SOLUTIONS PHARMACY | allowed | USPTO | 35 | 2023-06-23 |
| LONGAVO | allowed | USPTO | 5 | 2023-06-14 |
| BRAVAYIS | abandoned | USPTO | 5 | 2023-06-14 |
| FIDALTO | allowed | USPTO | 5 | 2023-06-14 |
| NEOLESK | abandoned | USPTO | 5 | 2023-06-14 |
| ZELVRI | abandoned | USPTO | 5 | 2023-06-14 |
| TIZAYA | abandoned | USPTO | 5 | 2023-06-14 |
| BEAUTESSE | abandoned | USPTO | 5 | 2023-05-03 |
| SUPELLIA | abandoned | USPTO | 5 | 2023-04-19 |
| TRINQUIS | allowed | USPTO | 5 | 2023-04-19 |
| DEMTEGE | allowed | USPTO | 5 | 2023-04-19 |
| WELTRUZA | abandoned | USPTO | 5 | 2023-04-19 |
| YOU OWN THE DAY NOT TD | abandoned | USPTO | 5, 42 | 2023-04-14 |
API
Get this data via the API
Everything on this page comes from the Signa API. Pull Teva Pharmaceuticals USA, Inc.'s full portfolio into your own product.
GET/v1/entities/{id}/trademarksEvery trademark in the portfolio, filterable by office and class
GET/v1/entities/{id}/analyticsPortfolio totals, disputes and ownership changes
GET/v1/entities/{id}Company record, ticker, LEI and owner names
GET /v1/entities/{id}/trademarks
ID=ent_019fc41c-ecc5-76e9-863d-e500c53224ec
curl https://api.signa.so/v1/entities/$ID/trademarks \
-H "Authorization: Bearer $SIGNA_API_KEY"Response
{
"object": "list",
"data": [
{
"id": "tm_01a0aa63-324b-768a-8aba-d89ffb8568ad",
"mark_text": "GOMOSDI",
"office_code": "US",
"status": {
"stage": "examining"
},
"filing_date": "2026-09-15"
},
{
"id": "tm_019fd20a-e600-74a4-9bd0-ad9498acd604",
"mark_text": "DEJEVMA",
"office_code": "US",
"status": {
"stage": "pending_publication"
},
"filing_date": "2026-08-04"
}
],
"has_more": true
}